NO20054243L - Kombinasjon av desoksypeganin og mecamylamin for behandling av alkoholmisbruk. ion eller et salt derav (forkortelse: NTBC). kseptabelt salt saerlig caspofunginacetat - Google Patents
Kombinasjon av desoksypeganin og mecamylamin for behandling av alkoholmisbruk. ion eller et salt derav (forkortelse: NTBC). kseptabelt salt saerlig caspofunginacetatInfo
- Publication number
- NO20054243L NO20054243L NO20054243A NO20054243A NO20054243L NO 20054243 L NO20054243 L NO 20054243L NO 20054243 A NO20054243 A NO 20054243A NO 20054243 A NO20054243 A NO 20054243A NO 20054243 L NO20054243 L NO 20054243L
- Authority
- NO
- Norway
- Prior art keywords
- deoxypeganine
- mecamylamine
- treatment
- ntbc
- abbreviation
- Prior art date
Links
- WUFQLZTXIWKION-UHFFFAOYSA-N Deoxypeganine Chemical compound C1C2=CC=CC=C2N=C2N1CCC2 WUFQLZTXIWKION-UHFFFAOYSA-N 0.000 title abstract 4
- 208000007848 Alcoholism Diseases 0.000 title abstract 3
- VARHXCYGZKSOOO-UHFFFAOYSA-N Deoxyvasicinone Natural products C1=CC=C2C(=O)N(CCC3)C3=NC2=C1 VARHXCYGZKSOOO-UHFFFAOYSA-N 0.000 title abstract 2
- 206010001584 alcohol abuse Diseases 0.000 title abstract 2
- 208000025746 alcohol use disease Diseases 0.000 title abstract 2
- IMYZQPCYWPFTAG-IQJOONFLSA-N mecamylamine Chemical compound C1C[C@@H]2C(C)(C)[C@@](NC)(C)[C@H]1C2 IMYZQPCYWPFTAG-IQJOONFLSA-N 0.000 title abstract 2
- 229960002525 mecamylamine Drugs 0.000 title abstract 2
- 150000003839 salts Chemical class 0.000 title 2
- 108010020326 Caspofungin Proteins 0.000 title 1
- 229960000730 caspofungin acetate Drugs 0.000 title 1
- 150000002500 ions Chemical class 0.000 title 1
- OUBCNLGXQFSTLU-UHFFFAOYSA-N nitisinone Chemical compound [O-][N+](=O)C1=CC(C(F)(F)F)=CC=C1C(=O)C1C(=O)CCCC1=O OUBCNLGXQFSTLU-UHFFFAOYSA-N 0.000 title 1
- 229960001721 nitisinone Drugs 0.000 title 1
- OGUJBRYAAJYXQP-IJFZAWIJSA-N vuw370o5qe Chemical compound CC(O)=O.CC(O)=O.C1([C@H](O)[C@@H](O)[C@H]2C(=O)N[C@H](C(=O)N3CC[C@H](O)[C@H]3C(=O)N[C@H](NCCN)[C@H](O)C[C@@H](C(N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)N2)[C@@H](C)O)=O)NC(=O)CCCCCCCC[C@@H](C)C[C@@H](C)CC)[C@H](O)CCN)=CC=C(O)C=C1 OGUJBRYAAJYXQP-IJFZAWIJSA-N 0.000 title 1
- 239000013543 active substance Substances 0.000 abstract 1
- 201000007930 alcohol dependence Diseases 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Cephalosporin Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10318714A DE10318714B4 (de) | 2003-04-25 | 2003-04-25 | Wirkstoff-Kombinationen und Therapien zur Bekämpfung des Alkoholmissbrauches |
| PCT/EP2004/004033 WO2004096200A1 (de) | 2003-04-25 | 2004-04-16 | Kombination aus desoxypeganin und mecamylamin zur behandlung des alkoholmissbrauches |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20054243L true NO20054243L (no) | 2005-09-13 |
Family
ID=33304936
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20054243A NO20054243L (no) | 2003-04-25 | 2005-09-13 | Kombinasjon av desoksypeganin og mecamylamin for behandling av alkoholmisbruk. ion eller et salt derav (forkortelse: NTBC). kseptabelt salt saerlig caspofunginacetat |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20060199866A1 (de) |
| EP (1) | EP1617831A1 (de) |
| JP (1) | JP2006524647A (de) |
| KR (1) | KR20060006946A (de) |
| CN (1) | CN1771029A (de) |
| AR (1) | AR044067A1 (de) |
| AU (1) | AU2004233564A1 (de) |
| BR (1) | BRPI0410507A (de) |
| CA (1) | CA2523331A1 (de) |
| CL (1) | CL2004000881A1 (de) |
| DE (1) | DE10318714B4 (de) |
| EA (1) | EA200501514A1 (de) |
| MX (1) | MXPA05011249A (de) |
| MY (1) | MY136408A (de) |
| NO (1) | NO20054243L (de) |
| TW (1) | TW200427452A (de) |
| WO (1) | WO2004096200A1 (de) |
| ZA (1) | ZA200507213B (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2073813A2 (de) * | 2006-10-10 | 2009-07-01 | The University of Chicago | Zusammensetzungen mit einem benzodiazepin, einem alkohol aversiven mittel und einem missbrauch-aversiven mittel |
| CN108498493A (zh) * | 2017-02-27 | 2018-09-07 | 中国人民解放军第二军医大学 | 美加明防治晕动症或眩晕症的医药用途 |
| KR102728780B1 (ko) * | 2021-11-30 | 2024-11-08 | 이화여자대학교 산학협력단 | 데옥시바시시논을 유효성분으로 포함하는 미백용 조성물 및 상기 데옥시바시시논 제조방법 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3797494A (en) * | 1969-04-01 | 1974-03-19 | Alza Corp | Bandage for the administration of drug by controlled metering through microporous materials |
| US3742951A (en) * | 1971-08-09 | 1973-07-03 | Alza Corp | Bandage for controlled release of vasodilators |
| US3996934A (en) * | 1971-08-09 | 1976-12-14 | Alza Corporation | Medical bandage |
| US4031894A (en) * | 1975-12-08 | 1977-06-28 | Alza Corporation | Bandage for transdermally administering scopolamine to prevent nausea |
| DE3315272C2 (de) * | 1983-04-27 | 1986-03-27 | Lohmann Gmbh & Co Kg, 5450 Neuwied | Pharmazeutisches Produkt und Verfahren zu seiner Herstellung |
| US5316759A (en) * | 1986-03-17 | 1994-05-31 | Robert J. Schaap | Agonist-antagonist combination to reduce the use of nicotine and other drugs |
| DE3843239C1 (de) * | 1988-12-22 | 1990-02-22 | Lohmann Therapie Syst Lts | |
| AU750808B2 (en) * | 1997-10-03 | 2002-07-25 | Cary Medical Corporation | Compositon for the treatment of nicotine addiction containing a nicotine receptor antagonist and an anti-depressant or anti-anxiety drug |
| CA2393437C (en) * | 1998-12-16 | 2009-12-15 | University Of South Florida | Exo-s-mecamylamine formulation and use in treatment |
| DE19906974C2 (de) * | 1999-02-19 | 2003-10-09 | Lohmann Therapie Syst Lts | Verwendung von Desoxypeganin zur Behandlung des Alkoholismus |
| DE10129265A1 (de) * | 2001-06-18 | 2003-01-02 | Hf Arzneimittelforsch Gmbh | Wirkstoff-Kombination zur medikamentösen Sucht- oder Rauschmitteltherapie |
-
2003
- 2003-04-25 DE DE10318714A patent/DE10318714B4/de not_active Expired - Fee Related
-
2004
- 2004-04-16 EA EA200501514A patent/EA200501514A1/ru unknown
- 2004-04-16 KR KR1020057020318A patent/KR20060006946A/ko not_active Withdrawn
- 2004-04-16 US US10/554,350 patent/US20060199866A1/en not_active Abandoned
- 2004-04-16 BR BRPI0410507-9A patent/BRPI0410507A/pt not_active Application Discontinuation
- 2004-04-16 AU AU2004233564A patent/AU2004233564A1/en not_active Abandoned
- 2004-04-16 EP EP04727830A patent/EP1617831A1/de not_active Withdrawn
- 2004-04-16 JP JP2006505158A patent/JP2006524647A/ja active Pending
- 2004-04-16 CA CA002523331A patent/CA2523331A1/en not_active Abandoned
- 2004-04-16 MX MXPA05011249A patent/MXPA05011249A/es not_active Application Discontinuation
- 2004-04-16 CN CNA2004800094893A patent/CN1771029A/zh active Pending
- 2004-04-16 WO PCT/EP2004/004033 patent/WO2004096200A1/de not_active Ceased
- 2004-04-22 MY MYPI20041476A patent/MY136408A/en unknown
- 2004-04-23 TW TW093111538A patent/TW200427452A/zh unknown
- 2004-04-23 AR ARP040101378A patent/AR044067A1/es unknown
- 2004-04-26 CL CL200400881A patent/CL2004000881A1/es unknown
-
2005
- 2005-09-08 ZA ZA200507213A patent/ZA200507213B/en unknown
- 2005-09-13 NO NO20054243A patent/NO20054243L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CN1771029A (zh) | 2006-05-10 |
| TW200427452A (en) | 2004-12-16 |
| BRPI0410507A (pt) | 2006-06-20 |
| AU2004233564A1 (en) | 2004-11-11 |
| US20060199866A1 (en) | 2006-09-07 |
| JP2006524647A (ja) | 2006-11-02 |
| WO2004096200A1 (de) | 2004-11-11 |
| ZA200507213B (en) | 2006-05-31 |
| EP1617831A1 (de) | 2006-01-25 |
| CA2523331A1 (en) | 2004-11-11 |
| MXPA05011249A (es) | 2005-12-14 |
| AR044067A1 (es) | 2005-08-24 |
| DE10318714A1 (de) | 2004-11-18 |
| KR20060006946A (ko) | 2006-01-20 |
| CL2004000881A1 (es) | 2005-01-21 |
| DE10318714B4 (de) | 2006-03-23 |
| EA200501514A1 (ru) | 2006-04-28 |
| MY136408A (en) | 2008-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Rosenstock et al. | Efficacy and safety of empagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, as add‐on to metformin in type 2 diabetes with mild hyperglycaemia | |
| NO20051987L (no) | Behandling av soppinfeksjoner. | |
| NO340679B1 (no) | Pyridazinonderivativer, farmasøytiske preparater omfattende slike og slike forbindelser og preparater for anvendelse i terapeutisk aktive substanser til behandling og forebygging av sykdommer | |
| WO2008040534A3 (en) | Non-mucoadhesive film dosage forms | |
| BRPI0413427A (pt) | derivados de piridilpirrol ativos como inibidores da cinase | |
| NO20080220L (no) | Formuleringer med hoy medikament belastning og doseringsformer | |
| BR0314797A (pt) | Derivados da pirimidineamida e o uso dos mesmos | |
| NO20071354L (no) | anvendelse av samme Butylftalid selvemulsifiserene medikamentavgivelsessystem, samt fremgangsmater for fremstilling og anvendelse av samme. | |
| ATE470443T1 (de) | Indol-1-yl-essigsäurederivate | |
| UA102254C2 (ru) | Жидкий состав для деферипрона с приятным вкусом | |
| DE60108489D1 (de) | Kombinationstherapien mit gefässschädigender aktivität | |
| CY1107819T1 (el) | Φαρμακευτικη διαμορφωση της ολανζαπινης | |
| CY1117174T1 (el) | ΧΡΗΣΗ 24-norUDCA ΓΙΑ ΤΗΝ ΑΓΩΓΗ ΧΟΛΟΣΤΑΤΙΚΩΝ ΝΟΣΗΜΑΤΩΝ ΤΟΥ ΗΠΑΤΟΣ | |
| NO20055891L (no) | Kinazolinderivater som aurorakinaseinhibitorer | |
| WO2004105485A3 (en) | Inducible release vehicles | |
| Iorizzo et al. | Today's treatments options for onychomycosis | |
| EA200601901A1 (ru) | Композиции, содержащие иммуномодулирующие соединения для лечения и управления течением миелодиспластических синдромов и способы с их использованием | |
| ATE451934T1 (de) | Pharmazeutische zusammensetzung zur behandlung von rhinitiden | |
| NO20055631L (no) | Doseringsform inneholdende pantoprazol som aktiv ingrediens | |
| WO2008128191A3 (en) | Oral cephalotaxine dosage forms | |
| DK1414467T3 (da) | Topisk behandling af mastalgi | |
| NO20073575L (no) | Farmasoytiske sammensetninger for behandling av cellulitt | |
| NO20054243L (no) | Kombinasjon av desoksypeganin og mecamylamin for behandling av alkoholmisbruk. ion eller et salt derav (forkortelse: NTBC). kseptabelt salt saerlig caspofunginacetat | |
| NO984974L (no) | Middel som forbedrer pulmonar sirkulasjon | |
| DE602004029993D1 (de) | Pharmazeutische zusammensetzung zur behandlung von drogenabhängigkeit |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |